Results 1 to 10 of about 33,363 (246)

Hemophilia A and Hemophilia B: Different Types of Diseases?

Seminars in Thrombosis and Hemostasis, 2013
Elena Santagostino
exaly  

Gene Therapy for Hemophilia

Molecular Therapy, 2017
Andrew Davidoff, Arthur W Nienhuis, Amit C Nathwani   +2 more
exaly  

Hemophilia A in the third millennium

Blood Reviews, 2013
Pier Mannuccio Mannucci, Massimo Franchini   +1 more
exaly  

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99

Journal of Thrombosis and Haemostasis, 2004
exaly  

Occurrence of hemophilia in the United States

1998
John Soucie
exaly  

Prevalence and Risk Factors for Hypertension in Hemophilia

Hypertension, 2013
Nicholas Kolaitis, Matthew Allison, Jill Waalen   +2 more
exaly  

Molecular etiology of factor VIII deficiency in hemophilia A

Human Mutation, 1995
Edward Tuddenham, S E Antonarakis
exaly  

International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology

Journal of Thrombosis and Haemostasis
Pantep Angchaisuksiri, Roberta Gualtierotti, Michael Makris   +2 more
exaly  

Updates on Novel Non-Replacement Drugs for Hemophilia

Pharmaceuticals, 2022
Over the last decade, the world of hemophilia has experienced an unprecedented therapeutic advance, thanks to the progress in bioengineering technologies, leading to the introduction of drugs with novel mechanisms of action based on restoring thrombin ...
Sara Arcudi, Roberta Gualtierotti, Flora Peyvandi   +2 more
exaly   +3 more sources

The State of Shared Decision‐Making in Immune Thrombocytopenia: A Narrative Review and Health Care Provider Perspective [PDF]

Health Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Advances in the treatment of immune thrombocytopenia (ITP) have broadened the landscape of treatment options for patients. Shared decision‐making, a collaborative process between a patient and their health care team, is encouraged for these patients. The ultimate goal of shared decision‐making is to personalize treatment to
Shivi Jain, Kelsey Kuhel, Rose Cree, Michael D. Tarantino   +3 more
wiley   +2 more sources